Synthix Global Pharma Solutions Limited - Board Members
Founded in 2025 and headquartered in Maharashtra, India.
2025 Thane, Maharashtra (India) Active
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kausalya Santhanam Appointed as Director since April 2025 | Director | 29-Apr-2025 | Current |
Manish Gupta Appointed as Director since April 2025 | Director | 29-Apr-2025 | Current |
Mohan Muthunarayanan Appointed as Additional Director since January 2026 | Additional Director | 01-Jan-2026 | Current |
Ramakrishnan Rajagopal Appointed as Director since April 2025 | Director | 29-Apr-2025 | Current |
Sarat Kumar Asuri Appointed as Director since May 2025 | Director | 28-May-2025 | Current |
Ramesh Appointed as Individual Subscriber since April 2025 | Individual Subscriber | 29-Apr-2025 | Current |
Venkatramani Raghavan Appointed as Individual Subscriber since April 2025 | Individual Subscriber | 29-Apr-2025 | Current |
Premium access Complete director detailsUnlock the complete director and KMP records available for Synthix Global Pharma Solutions Limited.
Verified entity values are shown only after access is granted. | |||
People Timeline
Explore the timeline of key personnel in Synthix Global Pharma Solutions Limited's leadership journey.
Loading...
Frequently Asked Questions
You can contact Synthix Global Pharma Solutions Limited through their registered address at Cyber One, Unit No. 902, Sector 30A, Plot No. 4 & 6, Vashi, Navi Mumbai, Thane Maharashtra, 400703, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Synthix Global Pharma Solutions Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- RAMESH
- RAMAKRISHNAN RAJAGOPAL
- VENKATRAMANI RAGHAVAN
- MOHAN MUTHUNARAYANAN
- MANISH GUPTA
- KAUSALYA SANTHANAM
- SARAT KUMAR ASURI
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.